Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Surgical Case Reports|October 6, 2025
Innovative Approach to Pediatric Peutz-Jeghers Syndrome: Simultaneously Performing Laparoscopic Reduction of Polyp-Induced Intussusception and Polypectomy with Double-Balloon EndoscopyNaoko Mise, Yasushi Fuchimoto, Takahiro Shimizu, et al.
Journal of Pediatric Surgery|May 17, 2015
Evidence for viral infection as a causative factor of human biliary atresiaTakeshi Saito, Keita Terui, Tetsuya Mitsunaga, et al.
Pediatric Reports|August 13, 2015
Risk Factors for Intestinal Obstruction After Ladd ProcedureTetsuya Mitsunaga, Takeshi Saito, Keita Terui, et al.
Pediatric Reports|January 25, 2022
Larger Physique as a Risk Factor for Infantile Appendicitis: A Retrospective StudyKatsuhiro Nishimura, Keita Terui, Naoko Mise, et al.
Journal of Medical Case Reports|February 6, 2015
Hybrid video-assisted thoracoscopic surgery lobectomy of fissureless congenital cystic adenomatoid malformation: a case reportMitsuyuki Nakata, Shigetoshi Yoshida, Takeshi Saito, et al.
Pediatric Surgery International|October 12, 2017
Frequency and proliferative response of circulating invariant natural killer T cells in pediatric patients with malignant solid tumorsTomoro Hishiki, Naoko Mise, Kazuaki Harada, et al.
Pediatric Surgery International|November 4, 2010
Src kinase family inhibitor PP2 induces aggregation and detachment of neuroblastoma cells and inhibits cell growth in a PI3 kinase/Akt pathway-independent mannerTomoro Hishiki, Takeshi Saito, Yoshiharu Sato, et al.
Pediatric Surgery International|October 12, 2017
Invariant natural killer T infiltration in neuroblastoma with favorable outcomeTomoro Hishiki, Naoko Mise, Kazuaki Harada, et al.
Journal of Pediatric Surgery|December 5, 2024
Prediction of Intestinal Perforation by Daily Radiographic Findings in Very Low Birth Weight Infants With Meconium IleusYoshio Katsumata, Keita Terui, Ayako Takenouchi, et al.
Cancer Immunology, Immunotherapy : CII|September 16, 2016
Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cellsToshiko Kamata, Akane Suzuki, Naoko Mise, et al.
Pageof 2